SHORT MINI FUTURE WARRANT - JOHNSON & JOHNSON Share Price

Certificat

DE000GP7W2J3

Market Closed - BOERSE MUENCHEN 11:55:02 11/07/2024 pm IST
3.48 EUR -4.13% Intraday chart for SHORT MINI FUTURE WARRANT - JOHNSON & JOHNSON
Current month-8.90%
1 month-8.66%
Date Price Change
11/24/11 3.48 -4.13%
10/24/10 3.63 -5.22%
09/24/09 3.83 -1.03%
08/24/08 3.87 +0.52%
05/24/05 3.85 -0.77%

Real-time BOERSE MUENCHEN

Last update July 11, 2024 at 11:55 pm IST

More quotes

Static data

Product typeKnock-Out with Stop Loss
Buy / SellPUT
Underlying JOHNSON & JOHNSON
Issuer Goldman Sachs
WKN GP7W2J
ISINDE000GP7W2J3
Date issued 12/07/2023
Strike 187.6 $
Maturity Unlimited
Parity 10 : 1
Emission price 2.89
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 4.223
Lowest since issue 1.394
Spread 0.01
Spread %0.28%

Company Profile

Johnson & Johnson is one of the world's leading producers of healthcare products. Net sales break down by family of products as follows: - pharmaceutical products (55.4%): drugs intended for the treatment of cardiovascular diseases, oncological diseases, gastro-intestinal illnesses, infectious, immunological, neurological, dermatological diseases, etc.; - medical products and equipment (28.9%): diagnostic systems, orthopedic and gynecological equipment, surgical materials, etc. for use by healthcare professionals; - consumer health products (15.7%): OTC drugs (Tylenol, Sudafed, Benadryl, Zyrtec, Motrin, Nicorette and other brands), health and beauty products (Aveeno, Clean & Clear, Dr. CI:Labo, Neutrogena and OGX), baby care products (Johnson's and Aveeno Baby), oral care products (Listerine), feminine hygiene products (Stayfree and Carefree and o.b.), wound care products (Band-Aid and Neosporin) etc. At the end of 2022, Johnson & Johnson has 89 manufacturing facilities located in the United States (28), North America (9), Europe (27), Africa and Asia/Pacific (25). Net sales are distributed geographically as follows: the United States (51.2%), Europe (24.7%), Asia/Pacific and Africa (17.7%) and other (6.4%).
Sector
-
More about the company

Ratings for Johnson & Johnson

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Johnson & Johnson

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
23
Last Close Price
149.7 USD
Average target price
171.7 USD
Spread / Average Target
+14.71%
Consensus